Is family history sufficient to identify women with risk of venous thromboembolism before commencing the contraceptive pill?

被引：14

作者：

Aznar, J ^{[1
]}

Mira, Y ^{[1
]}

Vayá, A ^{[1
]}

Ferrando, F ^{[1
]}

Villa, P ^{[1
]}

机构：

[1] Hosp La Fe, Dept Biopatol Clin, E-46009 Valencia, Spain

来源：

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2002年 / 8卷 / 02期

关键词：

venous thrombosis; family history; oral contraceptives;

D O I：

10.1177/107602960200800209

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Oral contraceptives (OCs) increase risk of venous thromboembolic disease (VTE). The incidence of thomboembolic disease in healthy young women who are not taking OCs is 0.4-0.8/10,000, and in healthy young women using OCs, it is 3-4/10,000. To assess whether a family history of thromboembolism is a suitable tool to identify women who should not be given OCs, 50 women who suffered a VTE while taking OCs were studied. Only 16% of these women had family history which is why in our opinion, it is not a sufficient safeguard to recommending the use of OCs.

引用

页码：139 / 141

页数：3

共 5 条

[1]

Aznar J, 2000, HAEMATOLOGICA, V85, P1271

[2]

Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257

[3]

Schambeck CM, 1997, THROMB HAEMOSTASIS, V78, P1480

[4] Factor V Leiden: Should we screen oral contraceptive users and pregnant women? [J].

Vandenbroucke, JP ;

vanderMeer, FJM ;

Helmerhorst, FM ;

Rosendaal, FR .

BRITISH MEDICAL JOURNAL, 1996, 313 (7065) :1127-1130

[5] INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION [J].

VANDENBROUCKE, JP ;

KOSTER, T ;

BRIET, E ;

REITSMA, PH ;

BERTINA, RM ;

ROSENDAAL, FR .

LANCET, 1994, 344 (8935) :1453-1457

← 1 →